RASSF2

Ras association domain family member 2, the group of Ras association domain family

Basic information

Region (hg38): 20:4780023-4823608

Links

ENSG00000101265NCBI:9770OMIM:609492HGNC:9883Uniprot:P50749AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RASSF2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RASSF2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
16
clinvar
16
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 16 0 0

Variants in RASSF2

This is a list of pathogenic ClinVar variants found in the RASSF2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
20-4784299-T-G not specified Uncertain significance (May 26, 2024)3312973
20-4784335-C-T not specified Uncertain significance (Aug 26, 2022)2342244
20-4786234-C-T not specified Uncertain significance (Dec 07, 2021)2398117
20-4786300-G-A not specified Uncertain significance (Nov 17, 2023)3151926
20-4786303-A-T not specified Uncertain significance (Sep 16, 2021)2249760
20-4787737-C-A not specified Uncertain significance (Mar 21, 2024)3312972
20-4789631-G-A not specified Uncertain significance (Jun 07, 2024)3312971
20-4789672-C-A not specified Uncertain significance (Aug 17, 2021)2246260
20-4790533-C-T not specified Uncertain significance (Dec 20, 2023)3151925
20-4790537-G-A not specified Uncertain significance (Dec 06, 2021)2372386
20-4792598-T-C not specified Uncertain significance (Feb 10, 2022)2276196
20-4792608-T-A not specified Uncertain significance (Sep 30, 2021)2218605
20-4795875-C-T not specified Uncertain significance (Sep 20, 2023)3151924
20-4795902-C-T not specified Uncertain significance (Jul 14, 2021)2209869
20-4795911-C-T not specified Uncertain significance (Oct 20, 2021)2373071
20-4798015-G-C not specified Uncertain significance (Jun 21, 2022)2296015
20-4798021-G-A not specified Uncertain significance (Jan 29, 2024)3151923
20-4798056-T-C not specified Uncertain significance (Jan 26, 2022)2366403
20-4801021-T-C not specified Uncertain significance (Jan 24, 2023)2478746

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RASSF2protein_codingprotein_codingENST00000379400 1043623
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.06e-70.8621257170311257480.000123
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9001642000.8210.00001292114
Missense in Polyphen6374.0550.85072742
Synonymous0.2477375.70.9640.00000445629
Loss of Function1.541320.50.6340.00000119215

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002440.000242
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.0001420.000141
Middle Eastern0.000.00
South Asian0.0003270.000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Potential tumor suppressor. Acts as a KRAS-specific effector protein. May promote apoptosis and cell cycle arrest. Stabilizes STK3/MST2 by protecting it from proteasomal degradation. {ECO:0000269|PubMed:12732644, ECO:0000269|PubMed:16012945, ECO:0000269|PubMed:19525978}.;
Pathway
Hippo signaling pathway - multiple species - Homo sapiens (human) (Consensus)

Recessive Scores

pRec
0.128

Intolerance Scores

loftool
0.875
rvis_EVS
-0.2
rvis_percentile_EVS
38.82

Haploinsufficiency Scores

pHI
0.105
hipred
Y
hipred_score
0.598
ghis
0.525

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.969

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rassf2
Phenotype
cellular phenotype; endocrine/exocrine gland phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; growth/size/body region phenotype; skeleton phenotype; immune system phenotype; liver/biliary system phenotype;

Gene ontology

Biological process
skeletal system development;ossification;protein phosphorylation;cell cycle;positive regulation of protein autophosphorylation;negative regulation of peptidyl-serine phosphorylation;epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade;positive regulation of apoptotic process;regulation of osteoblast differentiation;regulation of osteoclast differentiation;positive regulation of protein kinase activity;positive regulation of JNK cascade;bone remodeling;homeostasis of number of cells;protein stabilization;negative regulation of NIK/NF-kappaB signaling
Cellular component
kinetochore;condensed chromosome kinetochore;nucleus;nucleoplasm;cytoplasm;Golgi apparatus;cytosol;plasma membrane;protein-containing complex
Molecular function
protein kinase activity;protein binding